Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring.

Maye JE, Betensky RA, Gidicsin CM, Locascio J, Becker JA, Pepin L, Carmasin J, Rentz DM, Marshall GA, Blacker D, Sperling RA, Johnson KA.

Neurobiol Aging. 2016 Apr;40:61-67. doi: 10.1016/j.neurobiolaging.2015.12.013. Epub 2015 Dec 28.

2.

Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers.

Gidicsin CM, Maye JE, Locascio JJ, Pepin LC, Philiossaint M, Becker JA, Younger AP, Dekhtyar M, Schultz AP, Amariglio RE, Marshall GA, Rentz DM, Hedden T, Sperling RA, Johnson KA.

Neurology. 2015 Jul 7;85(1):48-55. doi: 10.1212/WNL.0000000000001704. Epub 2015 Jun 10.

3.

Apathy is associated with increased amyloid burden in mild cognitive impairment.

Marshall GA, Donovan NJ, Lorius N, Gidicsin CM, Maye J, Pepin LC, Becker JA, Amariglio RE, Rentz DM, Sperling RA, Johnson KA.

J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):302-7. doi: 10.1176/appi.neuropsych.12060156.

4.

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.

Johnson KA, Sperling RA, Gidicsin CM, Carmasin JS, Maye JE, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, Murali Doraiswamy P, Carpenter AP, Clark CM, Joshi AD, Lu M, Grundman M, Mintun MA, Pontecorvo MJ, Skovronsky DM; AV45-A11 study group.

Alzheimers Dement. 2013 Oct;9(5 Suppl):S72-83. doi: 10.1016/j.jalz.2012.10.007. Epub 2013 Jan 30.

Supplemental Content

Loading ...
Support Center